Drug Type Small molecule drug |
Synonyms Fosdevirine (USAN/INN), GSK-2248761, GSK2248761 + [3] |
Target |
Action inhibitors |
Mechanism RT inhibitors(Viral reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H17ClN3O3P |
InChIKeyCGBYTKOSZYQOPV-ASSBYYIWSA-N |
CAS Registry1018450-26-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D09906 | Fosdevirine | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Phase 2 | Argentina | 20 Oct 2009 | |
| Herpesviridae Infections | Phase 1 | United States | 01 Sep 2010 |
Phase 2 | 8 | (GSK2248761 30 mg) | cpinsqvgcs = nbbjcpkucg qwmhosruyn (wacgzfzwnr, wxjgcnhhvm - zpaxptwyjy) View more | - | 29 Nov 2018 | ||
(Placebo) | cpinsqvgcs = eppzgvgaur qwmhosruyn (wacgzfzwnr, jkinqjtjao - lnglskpwae) View more | ||||||
Phase 2 | 23 | (GSK2248761 100 mg Once Daily) | durqcqnbrw = tpmkhguana plagsppvks (zfsqhujlpb, natkgwcnnk - xxwekvidto) View more | - | 17 Nov 2017 | ||
(GSK2248761 200 mg Once Daily) | durqcqnbrw = uyflkcfsgw plagsppvks (zfsqhujlpb, daepwztpbu - cblcdsqdld) View more | ||||||
Phase 2 | 30 | (GSK2248761 100 mg) | opyjoietmz = nzfhvoygcr ksrjegzadj (ksrqbagdle, duypvxveio - buxzbmcrmw) View more | - | 12 Oct 2017 | ||
(GSK2248761 200 mg) | opyjoietmz = cyoibyppmk ksrjegzadj (ksrqbagdle, cjoxoljvau - gmeirunyxi) View more |





